2014 Ibogaine Client Information Sheet
Clinical protocols Guideline moderate
AI-extracted · unverified · confirm at source
NZ client preparation document: informed consent, treatment expectations, safety protocols for ibogaine therapy.
Dosing: 10–25 mg/kg (weight-based) (oral)
Contraindications: Undisclosed medical history (full disclosure required for safety screening), Concurrent substance use during treatment (document warns this could be fatal), Reduced post-treatment opioid tolerance (risk of fatal overdose if substances taken during or after therapy)